Event-Driven Stocks

GE HealthCare Technologies Inc.

GEHCNasdaq

Healthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs5 good2 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21
Revenue$20.63B$19.67B$19.55B$18.34B$17.59B
Operating income$2.76B$2.63B$2.44B$2.52B$2.79B
Net income$2.08B$1.99B$1.57B$1.92B$2.25B
Total assets$36.91B$33.09B$32.45B$27.54B
Total liabilities$26.31B$24.44B$25.14B$17.95B
Equity$10.38B$8.45B$7.13B$9.36B$16.68B
EPS (diluted)$4.55$4.34$3.03$4.22$4.95
Shares out.457.3M455.4M453.9M100454.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
13.4%
Net margin
10.1%
Return on equity
20.1%
Return on assets
5.6%
Return on capital (ROCE)
9.9%
Liabilities / assets
71.3%
Debt / equity
2.53×
Book value / share
$22.70
Revenue growth (YoY)
4.8%
Net income growth (YoY)
4.6%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
1.99grey zone
Accruals / assets
0.3%clean
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
70
/ 100
Profitability 100Growth 100Catalyst 33Earnings quality 67Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

2 warning5 good
  • High leverage (liabilities > 70% of assets)
  • Altman Z″ in the grey zone
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202612.2M2.0+1.0%
Apr 30, 202612.1M2.0-0.7%
Apr 15, 202612.1M4.1-1.8%
Mar 31, 202612.4M3.1+12.0%
Mar 13, 202611.0M3.1+1.4%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)